These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20813756)

  • 21. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.
    Pogribny IP; Tryndyak VP; Woods CG; Witt SE; Rusyn I
    Mutat Res; 2007 Dec; 625(1-2):62-71. PubMed ID: 17586532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor α agonist induces mouse hepatomegaly through the spatial hepatocyte enlargement and proliferation.
    Yang J; Yang X; Zhang YF; Tian JN; Fan SC; Gao Y; Li HL; Cai CH; Huang M; Bi HC
    Acta Pharmacol Sin; 2023 Oct; 44(10):2037-2047. PubMed ID: 37193756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that reduction of hepatocyte growth factor (HGF) is not required for peroxisome proliferator-induced hepatocyte proliferation.
    Kiss A; Ortiz-Aguayo R; Sharp R; Merlino G; Thorgeirsson SS; Gonzalez FJ; Peters JM
    Carcinogenesis; 2001 Jun; 22(6):975-9. PubMed ID: 11375907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXR.
    Elcombe CR; Elcombe BM; Foster JR; Farrar DG; Jung R; Chang SC; Kennedy GL; Butenhoff JL
    Arch Toxicol; 2010 Oct; 84(10):787-98. PubMed ID: 20614104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive gene expression analysis of peroxisome proliferator-treated immortalized hepatocytes: identification of peroxisome proliferator-activated receptor alpha-dependent growth regulatory genes.
    Tien ES; Gray JP; Peters JM; Vanden Heuvel JP
    Cancer Res; 2003 Sep; 63(18):5767-80. PubMed ID: 14522898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
    Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes.
    Anderson SP; Howroyd P; Liu J; Qian X; Bahnemann R; Swanson C; Kwak MK; Kensler TW; Corton JC
    J Biol Chem; 2004 Dec; 279(50):52390-8. PubMed ID: 15375163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.
    Peters JM; Rusyn I; Rose ML; Gonzalez FJ; Thurman RG
    Carcinogenesis; 2000 Apr; 21(4):823-6. PubMed ID: 10753222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Treatment With WY-14643 Induces Tumorigenesis and Triglyceride Accumulation in Mouse Livers.
    Yang J; Fan S; Zhang Y; Huang M; Gao Y; Bi H
    Drug Metab Dispos; 2022 Dec; 50(12):1464-1471. PubMed ID: 36184081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha).
    Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC
    Toxicol Pathol; 2004; 32(5):591-9. PubMed ID: 15603543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor α positively regulates complement C3 expression but inhibits tumor necrosis factor α-mediated activation of C3 gene in mammalian hepatic-derived cells.
    Mogilenko DA; Kudriavtsev IV; Shavva VS; Dizhe EB; Vilenskaya EG; Efremov AM; Perevozchikov AP; Orlov SV
    J Biol Chem; 2013 Jan; 288(3):1726-38. PubMed ID: 23168409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators.
    Gonzalez FJ; Shah YM
    Toxicology; 2008 Apr; 246(1):2-8. PubMed ID: 18006136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.
    Xie C; Takahashi S; Brocker CN; He S; Chen L; Xie G; Jang K; Gao X; Krausz KW; Qu A; Levi M; Gonzalez FJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1396-1411. PubMed ID: 31195146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver.
    Jia Y; Qi C; Kashireddi P; Surapureddi S; Zhu YJ; Rao MS; Le Roith D; Chambon P; Gonzalez FJ; Reddy JK
    J Biol Chem; 2004 Jun; 279(23):24427-34. PubMed ID: 15150259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice.
    Yang Q; Xie Y; Alexson SE; Nelson BD; DePierre JW
    Biochem Pharmacol; 2002 May; 63(10):1893-900. PubMed ID: 12034374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prenatal peroxisome proliferator-activated receptor alpha (PPARalpha) agonism on postnatal development.
    Palkar PS; Anderson CR; Ferry CH; Gonzalez FJ; Peters JM
    Toxicology; 2010 Sep; 276(1):79-84. PubMed ID: 20637823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.
    Morimura K; Cheung C; Ward JM; Reddy JK; Gonzalez FJ
    Carcinogenesis; 2006 May; 27(5):1074-80. PubMed ID: 16377806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.
    Ren H; Aleksunes LM; Wood C; Vallanat B; George MH; Klaassen CD; Corton JC
    Toxicol Sci; 2010 Jan; 113(1):45-59. PubMed ID: 19850644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.